These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The comparative electrophysiologic and hemodynamic effects of verapamil in puppies and adult dogs. Gibson R; Driscoll D; Gillette P; Hartley C; Entman ML Dev Pharmacol Ther; 1981; 2(2):104-16. PubMed ID: 7472105 [TBL] [Abstract][Full Text] [Related]
4. [Effects of verapamil on left ventricular function in patients with myocardial infarction]. Cheng GM; Shao G; Pan ZY Zhonghua Xin Xue Guan Bing Za Zhi; 1987 Dec; 15(6):319-21, 368. PubMed ID: 3449347 [No Abstract] [Full Text] [Related]
5. Part I: pharmacologic and hemodynamic actions and interactions. Pharmacologic and hemodynamic mechanisms underlying the antianginal actions of verapamil. Singh BN; Chew CY; Josephson MA; Packer M Am J Cardiol; 1982 Oct; 50(4):886-93. PubMed ID: 6751064 [No Abstract] [Full Text] [Related]
6. [Clinical pathophysiological studies on coronary circulation. 3. The effects of so-called coronary vasodilator agents on coronary circulation in various diseases]. Osugi S Jpn Circ J; 1971 Feb; 35(2):268-80. PubMed ID: 5109720 [No Abstract] [Full Text] [Related]
7. Mechanism of action of verapamil in ischemic heart disease: observations on changes in systemic and coronary hemodynamics and coronary vasomobility. Chew CY; Brown BG; Singh BN; Hecht HS; Schnugg SJ; Wong M; Shah PM; Dodge HT Clin Invest Med; 1980; 3(1-2):151-8. PubMed ID: 7008996 [No Abstract] [Full Text] [Related]
8. Left ventricular function in patients with coronary artery disease after verapamil administration. Ferlinz J; Easthope JL; Aronow WS Clin Invest Med; 1980; 3(1-2):63-71. PubMed ID: 7471542 [No Abstract] [Full Text] [Related]
9. Differential effects of mibefradil, verapamil, and amlodipine on myocardial function and intracellular Ca(2+) handling in rats with chronic myocardial infarction. Min JY; Sandmann S; Meissner A; Unger T; Simon R J Pharmacol Exp Ther; 1999 Dec; 291(3):1038-44. PubMed ID: 10565822 [TBL] [Abstract][Full Text] [Related]
10. Pharmacological profile of valsartan, a non-peptide angiotensin II type 1 receptor antagonist. 5th communication: hemodynamic effects of valsartan in dog heart failure models. Yamamoto S; Hayashi N; Kometani M; Nakao K Arzneimittelforschung; 1997 May; 47(5):630-4. PubMed ID: 9205777 [TBL] [Abstract][Full Text] [Related]
12. Hemodynamic changes during posterior vessel off-pump coronary artery bypass: comparison between deep pericardial sutures and vacuum-assisted apical suction device. Chang WI; Kim KB; Kim JH; Ham BM; Kim YL Ann Thorac Surg; 2004 Dec; 78(6):2057-62. PubMed ID: 15561035 [TBL] [Abstract][Full Text] [Related]
13. [Chronic effects of hypertension on cardiac function in ischemic heart disease, particularly in myocardial infarction]. Shimizu M; Tsuyusaki T; Niizuma K; Mochizuki T; Noro C; Kikawada R; Ishii K; Nakazawa K Kokyu To Junkan; 1986 Aug; 34(8):891-8. PubMed ID: 3786957 [No Abstract] [Full Text] [Related]
14. Does combined single intravenous injection of doxorubicin and verapamil have any influence on hemodynamic parameters in rabbits? Stepień M; Drzewoski J Mater Med Pol; 1995; 27(1):19-22. PubMed ID: 8569271 [TBL] [Abstract][Full Text] [Related]
15. Acute hemodynamic effects of drugs acting on the renin-angiotensin system in acute heart failure. Nekooeian AA; Ogilvie RI; Zborowska-Sluis D Can J Cardiol; 1995 Jan; 11(1):59-64. PubMed ID: 7850666 [TBL] [Abstract][Full Text] [Related]
16. [Clinical significance of pressure measurement in the infarct-related coronary artery in acute myocardial infarction: evaluation of variables predicting recovery of left ventricular function in the convalescent stage]. Uemura R; Takayama M; Sekido M; Kiuchi K; Takano T J Cardiol; 2000 Apr; 35(4):247-55. PubMed ID: 10791268 [TBL] [Abstract][Full Text] [Related]
17. [Mechanism of the depression of the heart pumping function in experimental myocardial infarct]. Babiĭchuk GA; Belostotskiĭ AV; Artsybushev IuN; Kozlov AV; Chizhevskaia IV Patol Fiziol Eksp Ter; 1987; (1):27-30. PubMed ID: 3031571 [No Abstract] [Full Text] [Related]
18. Effects of verapamil, an antagonist of L-type calcium channels, on cardiovascular symptoms in alcohol withdrawal. Kähkönen S; Bondarenko BB; Lipsanen J; Zvartau EE Neuropsychobiology; 2008; 58(3-4):123-7. PubMed ID: 18997479 [TBL] [Abstract][Full Text] [Related]
19. [Role of the relaxation process in contractile function disturbance in various heart pathologies]. Kapel'ko VI Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1982; 5(1):99-107. PubMed ID: 7046765 [No Abstract] [Full Text] [Related]
20. [Influence of verapamil on the electrophysiologic and mechanical effects of ischemia and reperfusion]. Tucci PJ; Bregagnollo EA; Garcia RM Arq Bras Cardiol; 1982 Sep; 39(3):141-7. PubMed ID: 7186356 [No Abstract] [Full Text] [Related] [Next] [New Search]